EverFlex Post Approval Study
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 108 participants.
Also called NCT01680835
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 108 participants
- Sponsor
- Registry
-
NCT01680835
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT01680835. Allocation not applicable; no masking; primary purpose treatment. Start 2013-01-14 (actual); primary completion 2018-10-23 (actual). Results posted on 2019-12-26.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- EverFlex Post Approval Study
- Acronym
- DURABILITY PAS
- Condition
- Peripheral Arterial Disease
- Condition
- Lower Extremity Arterial Disease
- Intervention (Device)
- EverFlex™ Self-Expanding Peripheral Stent System
- Lead sponsor
- Medtronic Endovascular
Record details
- Record id
cardio:ct-nct01680835- Content hash
83e0d9e81d62592713ed200a685d47af6e650d63c40893eeecbf1bded1af0099